March 27, 2019 | Joanne Morrison
Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)
Director of Marketing and Public Relations
University of Maryland School of Medicine
Office: (410) 706-2884
Mobile: (202) 841-3369
Tuesday, April 13, 2021
UM School of Medicine Study Shows that Psychedelic Experience May Not be Required for Psilocybin’s Antidepressant-like Benefits
University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin—the active chemical in “magic mushrooms”— still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked. The new findings suggest that psychedelic drugs work in multiple ways in the brain, and it may be possible to deliver the fast-acting antidepressant therapeutic benefit without requiring daylong guided-therapy sessions.
Thursday, February 27, 2020
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Wednesday, October 16, 2019
Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb
As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.
Thursday, April 04, 2019
Health and addiction treatment officials from the Caroline County Health Department, Maryland Department of Health, the Maryland Opioid Operational Command Center, and the University of Maryland School of Medicine (UMSOM) in Denton, MD., launched the Eastern Shore Mobile Care Collaborative (ESMCC), a mobile system designed to provide state-of-the-art treatment for opioid disorders for those in need on the Maryland Eastern shore.
Tuesday, October 16, 2018
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Friday, January 05, 2018
Fighting Opioid Addiction from Baltimore to Garrett County: University of Maryland School of Medicine Rises to the Challenge
The opioid epidemic has been deadly for Maryland. In 2016, more than 2000 people in the state died from overdoses; in 2017, deaths rose another 40 percent, and deaths from the powerful synthetic opioid fentanyl were up nearly 140 percent. Last year, Gov. Larry Hogan declared a state of emergency in response to the opioid epidemic, saying the state needs an “all-hands-on-deck approach.”
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Wednesday, May 04, 2016
For years, scientists and doctors have known that ketamine can treat depression very rapidly, often working within hours, compared to weeks or months for widely used antidepressants. However, the drug, which is approved as an anesthetic, has major side effects – it is linked to hallucinations and dissociation - a sense of being outside your own body – and for these reasons is abused as a club drug. Not surprisingly, this limits its use in the treatment of depression.
Friday, December 18, 2015
Post-Doctoral Student at University of Maryland School of Medicine Awarded Grant to Study Relationship Between Stress and Depression
University of Maryland School of Medicine Department of Physiology Professor and Chair Scott M. Thompson, PhD, announced today that Tara LeGates, PhD, a post-doctoral student in his laboratory, has received a grant from the Brain & Behavior Research Foundation.
Monday, July 13, 2015
University of Maryland School of Medicine Scientists Identify Novel Compounds That May Treat Depression Rapidly With Few Side Effects
A new study by researchers at University of Maryland School of Medicine has identified promising compounds that could successfully treat depression in less than 24 hours while minimizing side effects. Although they have not yet been tested in people, the compounds could offer significant advantages over current antidepressant medications.